Clinical Development of Advanced Therapeutic Medicinal Product for Acute Kidney Injury

Project Information

ALOREN

Grant agreement ID: 101218588

DOI

10.3030/101218588

EC signature date 13 June 2025

Start date 1 June 2025

End date 31 May 2028

Funded under

• The European Innovation Council (EIC)

Total cost

No data

EU contribution

€ 2 499 999,00

Coordinated by

Kelifarma
Lithuania

CORDIS provides links to public deliverables and publications of HORIZON projects.

Links to deliverables and publications from FP7 projects, as well as links to some specific result types such as dataset and software, are dynamically retrieved from OpenAIRE .

Publications

Peer reviewed articles (2)

In vitro and ex vivo immunomodulatory effects of human placental mesenchymal stem cells in hidradenitis suppurativa

Author(s): Vaiva Jariene, Paulius Valiukevicius, Ruta Insodaite, Ugne Janonyte, Romaldas Maciulaitis, Justinas Maciulaitis, Astra Vitkauskiene, Evelina Zemaite, Christos C. Zouboulis, Skaidra Valiukeviciene
Published in: Frontiers in Immunology, Issue 16, 2025, ISSN 1664-3224
Publisher: Frontiers Media SA
DOI: 10.3389/FIMMU.2025.1642014

Placenta derived stem cells for acute kidney injury to chronic kidney disease prevention: biomarkers of kidney injury

Author(s): Gryguc A, Maciulaitis J, Mickevicius L, Laurinavicius A, Vaiciuliene G, Sutkeviciene N, Zigmantaite V, Grigaleviciute R, Bumblyte IA, Maciulaitis R
Published in: Kidney International Reports, Issue Volume 11, Issue 4 Supplement, Article 104520, 2026, ISSN 2468-0249
Publisher: Elsevier
DOI: 10.1016/J.EKIR.2026.02.104520